The use of unequal randomisation ratios in clinical trials: A review

被引:262
作者
Dumville, JC [1 ]
Hahn, S
Miles, JNV
Torgerson, DJ
机构
[1] Univ York, Dept Hlth Sci, York Trials Unit, Area 4, York YO10 5DD, N Yorkshire, England
[2] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Med Res Collaborating Ctr, Seoul 110744, South Korea
关键词
unequal randomisation; randomised controlled trials;
D O I
10.1016/j.cct.2005.08.003
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To examine reasons given for the use of unequal randomisation in randomised controlled trials (RCTs). Main Measures: Setting of the trial; intervention being tested; randomisation ratio; sample size calculation; reason given for randomisation. Methods: Review of trials using unequal randomisation. Databases and sources: Cochrane library, Medline, Pub Med and Science Citation Index. Results: A total of 65 trials were identified; 56 were two-armed trials and nine trials had more than two arms. Of the two-arm trials, 50 trials recruited patients in favour of the experimental group. Various reasons for the use of unequal randomisation were given. Six studies stated that they used unequal randomisation to reduce the cost of the trial, with one screening trial limited by the availability of the intervention. Other reasons for using unequal allocation were: avoiding loss of power from drop-out or crossover, ethics and the gaining of additional information on the treatment. Thirty seven trials papers (57%) did not state why they had used unequal randomisation and only 14 trials (22%) appeared to have taken the unequal randomisation into account in their sample size calculation. Conclusion: Although unequal randomisation offers a number of advantages to trials the method is rarely used and is especially under-utilised to reduce trial costs. Unequal randomisation should be considered more in trial design especially where there are large differences between treatment costs. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 71 条
[1]   Liposomal prostaglandin E(1) in acute respiratory distress syndrome: A placebo-controlled, randomized, double-blind, multicenter clinical trial [J].
Abraham, E ;
Park, YC ;
Covington, P ;
Conrad, SA ;
Schwartz, M .
CRITICAL CARE MEDICINE, 1996, 24 (01) :10-15
[2]   Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon nonresponsive chronic hepatitis C: a randomised trial [J].
Adinolfi, LE ;
Utili, R ;
Tonziello, A ;
Ruggiero, G .
GUT, 2003, 52 (05) :701-705
[3]  
AGNELLI G, 1992, THROMB HAEMOSTASIS, V67, P203
[4]   Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening [J].
Atkin, WS ;
Edwards, R ;
Wardle, J ;
Northover, JMA ;
Sutton, S ;
Hart, AR ;
Williams, CB ;
Cuzick, J .
JOURNAL OF MEDICAL SCREENING, 2001, 8 (03) :137-144
[5]   Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials [J].
Avins, AL .
JOURNAL OF MEDICAL ETHICS, 1998, 24 (06) :401-408
[6]   A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease [J].
Bae, CY ;
Cho, CY ;
Cho, K ;
Oh, BH ;
Choi, KG ;
Lee, HS ;
Jung, SP ;
Kim, DH ;
Lee, S ;
Choi, GD ;
Cho, H ;
Lee, H .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (12) :1566-1571
[7]   A tolerability study of pirenzepine ophthalmic gel in myopic children [J].
Bartlett, JD ;
Niemann, K ;
Houde, B ;
Allred, T ;
Edmondson, MJ ;
Crockett, RS .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2003, 19 (03) :271-279
[8]   Randomized controlled trial of hip protectors among women living in the community [J].
Birks, YF ;
Porthouse, J ;
Addie, C ;
Loughney, K ;
Saxon, L ;
Baverstock, M ;
Francis, RM ;
Reid, DM ;
Watt, I ;
Torgerson, DJ .
OSTEOPOROSIS INTERNATIONAL, 2004, 15 (09) :701-706
[9]   Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease [J].
Canal, N ;
Imbimbo, BP ;
Bassi, S ;
Calloni, E ;
DeSimone, V ;
Albizzati, MG ;
Franceschi, M ;
Alberoni, M ;
Rinaldi, L ;
Erminio, F ;
Gerini, AM ;
Donato, F ;
Mamoli, A ;
Partziguian, T ;
Galavotti, B ;
Zerbi, D ;
Valenti, L ;
Lattuada, P ;
Lucchelli, F ;
Marforio, S ;
DiPalma, F ;
Roncoroni, M ;
Cappelletti, M ;
Montanini, R ;
Perini, M ;
DeFanti, CA ;
Tiraboschi, P ;
Ruggeri, E ;
Frattola, L ;
Piolti, R ;
Zincone, A ;
Fieschi, C ;
Giubilei, F ;
Tisei, P ;
Mosco, A ;
Luzzana, M ;
Caramenti, C ;
Zecca, L ;
DiMarzio, G ;
Lucchelli, PE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (02) :218-228
[10]   TREATMENT OF FILARIAL LYMPHEDEMA AND ELEPHANTIASIS WITH 5,6-BENZO-ALPHA-PYRONE (COUMARIN) [J].
CASLEYSMITH, JR ;
WANG, CT ;
CASLEYSMITH, JR ;
CUI, ZH .
BRITISH MEDICAL JOURNAL, 1993, 307 (6911) :1037-1041